SEC Form 4 · accession 0001127602-15-006668
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas F Ackerman
Officer — Corp. Executive VP & CFO
Period of report
Feb 17, 2015
Accepted (ET)
Feb 18, 2015 · 2:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 17, 2015 | S | 100 | $73.72 | D | 104,711 | D | |
| Common Stock | Feb 17, 2015 | S | 100 | $73.73 | D | 104,611 | D | |
| Common Stock | Feb 17, 2015 | S | 100 | $73.74 | D | 104,511 | D | |
| Common Stock | Feb 17, 2015 | S | 100 | $73.75 | D | 104,411 | D | |
| Common Stock | Feb 17, 2015 | S | 100 | $73.76 | D | 104,311 | D | |
| Common Stock | Feb 17, 2015 | S | 100 | $73.78 | D | 104,211 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.